Posted by Michael Wonder on 14 Jul 2020
Proposed changes to PHARMAC model could ease brand switch issues
14 July 2020 - The way New Zealand secures its medicines could be changing, as the Government’s drug buying agency seeks feedback about its model.
PHARMAC’s current model centres on sole-supply agreements. Typically, drug companies put in a tender (bid) to supply the whole of the New Zealand market for a medication and PHARMAC awards one the sole contract – generally to get the best bang for buck.
Recent medicine supply issues saw questions raised about the strength of this model, prompting calls for it to be reviewed.
